Atea Pharmaceuticals, Inc.
AVIRBiotechnology
$4.31+0.94%As of Oct 29vs prior close
- Market cap
- $345.7M
- P/E (TTM)
- –
- From 52W high
- −29.92%
- EPS (LTM)
- -$2.08
- Revenue (YE21)
- $351.4M
- Dividend yield
- 0.00%
Nomior Score
57
Steady ProfileSpeculativeTop 33% of the scored universe
Growth—
Quality38
Value—
Momentum87
Resilience50
Growth
+622.49%revenue a year over 1 fiscal year
YE20 $48.6MYE21 $351.4M
Connections
Revenue to profitYE21
34% of revenue became net profit, up 57 pts on a year.
Who owns it
2funds